title: New drug for type 2 diabetes is no better than older, cheaper treatments, says institute.
authors.forename: Ned
authors.initials: N
authors.lastname: Stafford
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000191:economics / Q000627:therapeutic use*; D005858:Germany; D006801:Humans; D000069476:Linagliptin; D011687:Purines / Q000191:economics* / Q000627:therapeutic use*; D011799:Quinazolines / Q000191:economics* / Q000627:therapeutic use*
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D011687:Purines; D011799:Quinazolines; D000069476:Linagliptin